Cameron Genxuan Lian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cameron Genxuan Lian has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
Andres F. Vacas
2 shared publicationsBridget E. Luce
2 shared publicationsFelicia G. Deng
2 shared publicationsInna Aphasizheva
2 shared publications- Jonathan A. Stefely
Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Medical School, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Howard Hughes Medical Institute, Massachusetts General Hospital, Boston, MA 02114, USA
2 shared publications Keith D. Rivera
Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
2 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by Elsevier in Current Biology
- Vol. 36 (20) , 5141-5155.e10
Mitochondrial proteome of the apicomplexan Babesia divergens
- 1 October 2026
- Published by Elsevier in Current Biology
- Vol. 36 (20) , 5141-5155.e10
Open AccessMitochondrial proteome of the apicomplexan Babesia divergens
- Open Access
- 1 October 2026
- Published by Elsevier in Current Biology
A high-confidence inventory of the proteins in the mitochondrion-related organelle of Giardia
- 1 October 2026
- Published by Elsevier in Current Biology
Open AccessA high-confidence inventory of the proteins in the mitochondrion-related organelle of Giardia
- Open Access
- 9 April 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 392 (6794) , eaea2100
Luminal surface proteome of the brain vasculature uncovers blood-brain barrier regulators
At the blood-tissue interface, vasculature luminal surface is critical for molecular transport, signaling transduction, and cell extravasation. Here, we present a method for proteomic profiling of the vasculature luminal surface in vivo, broadly applicable to any vertebrate. Quantitative mass spectrometry revealed the luminal surface proteome of the mouse brain vasculature and its temporal evolution from development to aging. In vivo genetic perturbation found that the arginine transporter SLC7A1 and the nitric oxide synthase NOS3 are needed for blood-brain barrier integrity in neonatal but not adult mice, whereas the hyaluronan degradation enzyme HYAL2 safeguards the barrier throughout the lifespan. By characterizing the proteomic dynamics of the vasculature luminal surface, the study links the metabolism of nitric oxide and hyaluronan to blood-brain barrier integrity.
- 9 April 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 392 (6794) , eaea2100
Open AccessLuminal surface proteome of the brain vasculature uncovers blood-brain barrier regulators
At the blood-tissue interface, vasculature luminal surface is critical for molecular transport, signaling transduction, and cell extravasation. Here, we present a method for proteomic profiling of the vasculature luminal surface in vivo, broadly applicable to any vertebrate. Quantitative mass spectrometry revealed the luminal surface proteome of the mouse brain vasculature and its temporal evolution from development to aging. In vivo genetic perturbation found that the arginine transporter SLC7A1 and the nitric oxide synthase NOS3 are needed for blood-brain barrier integrity in neonatal but not adult mice, whereas the hyaluronan degradation enzyme HYAL2 safeguards the barrier throughout the lifespan. By characterizing the proteomic dynamics of the vasculature luminal surface, the study links the metabolism of nitric oxide and hyaluronan to blood-brain barrier integrity.